Anthropic wants to develop its own drugs
Anthropic launches Claude Science workbench for drug discovery and research.
“At the event "The Briefing: AI for Science" earlier this week, Anthropic announced Claude Science, a new "AI workbench for scientists" that pulls fragmented tools…”
Why it matters
Weekly Silicon's editorial model scored this 4.05/10 overall, reading it above all as an industry story with cross-cutting implications. Its strongest dimension is regional relevance at 7/10 — direct impact on US technology hubs rather than a purely overseas development — with technology breakthrough close behind at 5/10, pointing to a genuine capability or engineering advance rather than a routine product update. The impact is global rather than tied to one US hub, so the thing to watch is how it filters into domestic supply chains and hiring.
Derived from the AI score breakdown below.
AI score breakdown
A composite of 4.05/10 put this story at #21 for Friday, July 3, 2026, driven mostly by regional relevance (7/10) and technology breakthrough (5/10).
Composite is the weighted sum of the five dimensions. How scoring works →
Companies in this story
Related stories
- Claude, Codex, and Hermes installed unowned code inside corporate networks · 2026-08-31
- An Anthropic researcher just gave us a peek at self-improving AI · 2026-08-29
- Anthropic reportedly commits US$45 billion to Nscale for AI computing capacity · 2026-08-28
- Anthropic hires Google chip veteran Amir Salek as part of push into hardware · 2026-08-23
- I legitimately think Anthropic is worth $100B more than it was a week ago · 2026-04-09